Growth Metrics

Jazz Pharmaceuticals (JAZZ) Shares Issued (2016 - 2025)

Historic Shares Issued for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Q3 2025 value amounting to $733000.0.

  • Jazz Pharmaceuticals' Shares Issued rose 421176.47% to $733000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 5697.89%. This contributed to the annual value of $20.6 million for FY2024, which is 5555.87% down from last year.
  • As of Q3 2025, Jazz Pharmaceuticals' Shares Issued stood at $733000.0, which was up 421176.47% from $10.5 million recorded in Q2 2025.
  • Jazz Pharmaceuticals' Shares Issued's 5-year high stood at $51.9 million during Q2 2021, with a 5-year trough of $17000.0 in Q3 2024.
  • In the last 5 years, Jazz Pharmaceuticals' Shares Issued had a median value of $11.4 million in 2025 and averaged $17.0 million.
  • In the last 5 years, Jazz Pharmaceuticals' Shares Issued plummeted by 9969.16% in 2024 and then surged by 421176.47% in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Shares Issued (Quarter) stood at $18.2 million in 2021, then skyrocketed by 66.15% to $30.2 million in 2022, then crashed by 70.64% to $8.9 million in 2023, then increased by 3.87% to $9.2 million in 2024, then tumbled by 92.03% to $733000.0 in 2025.
  • Its Shares Issued was $733000.0 in Q3 2025, compared to $10.5 million in Q2 2025 and $11.4 million in Q1 2025.